HIV/AIDS

Prescription Opioids Up Pneumonia Risk in Patients With, Without HIV

Prescription Opioids Up Pneumonia Risk in Patients With, Without HIV

Risk greatest with higher-dose opioids and opioids with immunosuppressive properties.

Web-Based Treatments for Depression in HIV-Infected Individuals

Web-Based Treatments for Depression in HIV-Infected Individuals

Depression is a common comorbidity in people living with HIV, with lifetime prevalence estimates ranging from 22% to 61%.

Genotype G Linked With Liver Fibrosis in Hepatitis B-HIV Coinfection

Genotype G Linked With Liver Fibrosis in Hepatitis B-HIV Coinfection

Investigators sought to determine the association between liver fibrosis and hepatitis B virus genotype G in patients with comorbid HIV and HBV.

Case Study: Abdominal Pain, Malaise, and a Bruise on the Leg

Case Study: Abdominal Pain, Malaise, and a Bruise on the Leg

By

A 44-year-old man presents to the hospital with generalized abdominal pain, malaise, subjective low-grade fever, and a bruise on his left shin. He has an extensive medical history including HIV, hypertension, diabetes, and GERD, but he denies vomiting or diarrhea.

Infant HIV Infection Increases the Risk for Congenital CMV Infection

Infant HIV Infection Increases the Risk for Congenital CMV Infection

HIV-exposed infants have high rates of congenital cCMV infection, and in utero HIV infection seems to be a major risk factor for cCMV.

Hispanics With HIV Face Higher Risk for HPV-Related Cancer

Hispanics With HIV Face Higher Risk for HPV-Related Cancer

HIV-infected Hispanics have an increased risk for human papillomavirus-related cancers than Hispanics in the general population.

Advance Care Planning Lowers Symptoms in Teens With HIV

Advance Care Planning Lowers Symptoms in Teens With HIV

Family-centered pediatric advance care planning is associated with a lower likelihood of symptoms and suffering for adolescents with HIV.

2014 to 2016 Saw 470% Increase in HIV PrEP Use in US

2014 to 2016 Saw 470% Increase in HIV PrEP Use in US

Seven percent of those with indications for PrEP were prescribed PrEP, including 2.1% of women.

Glecaprevir/Pibrentasvir Is Safe, Efficacious for HCV/HIV-1 Coinfection

Glecaprevir/Pibrentasvir Is Safe, Efficacious for HCV/HIV-1 Coinfection

Analysis of 2 phase 3 clinical trials evaluating the safety/efficacy of glecaprevir/pibrentasvir in people with HCV coinfected with HIV-1 found an overall sustained virologic response of 98% at week 12 of treatment in those with or without cirrhosis.

A Single Combination Tablet Suppresses HIV Load Through 48 Weeks

A Single Combination Tablet Suppresses HIV Load Through 48 Weeks

A combination single tablet once-a-day regimen of doravirine/lamivudine/tenofovir disoproxil fumarate demonstrated non-inferiority and no significant adverse events when compared with continuation of established antiretroviral therapy in adults infected with HIV-1.

HIV Infection Diagnoses on the Rise in Young Homosexual Men

HIV Infection Diagnoses on the Rise in Young Homosexual Men

Number of HIV diagnoses in those aged 13 to 29 4x higher than those aged 50 years.

Patrons of 'Vampire Facial' Spa May Have Been Exposed to HIV

Patrons of 'Vampire Facial' Spa May Have Been Exposed to HIV

Inspection at the VIP Spa in Albuquerque detected practices that might spread HIV or hepatitis B and C.

FDA Approves Two New Oral Treatments for HIV-1 Infection

FDA Approves Two New Oral Treatments for HIV-1 Infection

By

Delstrigo is approved as a complete regimen whereas Pifeltro is to be administered in combination with other antiretrovirals.

Risk of Thyroid Dysfunction Not Associated With HIV Status

Risk of Thyroid Dysfunction Not Associated With HIV Status

By

Compared with uninfected individuals, people with HIV controlled with combination antiretroviral therapy are not at increased risk of developing thyroid dysfunction.

Patient Navigation Associated With Positive Outcomes in HIV

Patient Navigation Associated With Positive Outcomes in HIV

By

Patient navigation may be considered an effective strategy to enhance engagement and continuation in disease treatment among people with HIV.

1997 to 2015 Saw Increase in HIV Viral Suppression Rates

1997 to 2015 Saw Increase in HIV Viral Suppression Rates

Lower odds of having detectable viral load for older adults and those using ISTI-based regimen.

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for 9 of 10 patients with virology failure, rebound.

Intervention Cuts Risk for HIV in Young Transgender Women

Intervention Cuts Risk for HIV in Young Transgender Women

Intervention group had greater reduction in condomless sex acts vs standard of care group.

International Antiviral Society-USA Updates Recommendations for HIV Treatment and Prevention

International Antiviral Society-USA Updates Recommendations for HIV Treatment and Prevention

The International Antiviral Society-USA Panel has updated its recommendations for the management and prevention of HIV infection, to reflect the most current data on new treatment regimens and strategies.

Low Rates of Syphilis Testing in High-Risk Men Who Are HIV Positive

Low Rates of Syphilis Testing in High-Risk Men Who Are HIV Positive

Close to one-third of sexually active HIV-positive men who have sex with men (MSM) have not received syphilis screening in the past 12 months.

HIV, Syphilis Screening Low With ED-Diagnosed PID in Adolescents

HIV, Syphilis Screening Low With ED-Diagnosed PID in Adolescents

Findings among teens diagnosed with pelvic inflammatory disease in the emergency department.

Guidelines for ART Updated for Those With or at Risk for HIV

Guidelines for ART Updated for Those With or at Risk for HIV

ART recommended for almost all HIV-infected; should be initiated as soon as possible post diagnosis.

Successful Screening and Referral for HIV, Hepatitis C in a Trauma Population

Successful Screening and Referral for HIV, Hepatitis C in a Trauma Population

Investigators added hepatitis C virus and HIV screening tests to standard trauma activation laboratory orders.

HPV Vaccine Failure Rates May Be Higher in Women, Girls With HIV

HPV Vaccine Failure Rates May Be Higher in Women, Girls With HIV

By

Vaccinated women and girls living with HIV may be at greater risk for HPV vaccine failure compared with women and girls without HIV.

Single High-Dose Liposomal Amphotericin B Effectively Treats HIV-Associated Cryptococcal Meningitis

Single High-Dose Liposomal Amphotericin B Effectively Treats HIV-Associated Cryptococcal Meningitis

Single high-dose liposomal amphotericin B (L-AmB) is non-inferior to daily dosed L-AmB at the standard dose in treatment of fungal clearance in HIV-associated cryptococcal meningitis.

Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV Positive Patients

Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV Positive Patients

Cirrhosis is associated with an increased risk for diabetes mellitus among patients living with HIV.

Efavirenz Does Not Increase Depression, Suicidal Ideation in HIV-Infected

Efavirenz Does Not Increase Depression, Suicidal Ideation in HIV-Infected

No increased risk of depression or suicidal ideation among persons living with HIV in Uganda.

National HIV Testing Day Is on June 27

National HIV Testing Day Is on June 27

Annual occasion is a good time for health care providers to encourage testing

FDA: Possible Risk of Neural Tube Birth Defects With Certain HIV Meds

FDA: Possible Risk of Neural Tube Birth Defects With Certain HIV Meds

By

The Agency has received reports of serious neural tube birth defects involving the brain, spine, and spinal cord in babies born to women who received dolutegravir for HIV treatment.

FDA approves antiretroviral therapy for multidrug-resistant HIV

FDA approves antiretroviral therapy for multidrug-resistant HIV

By

The FDA has approved Trogarzo for heavily treated adult patients living with HIV and whose HIV infections cannot be successfully treated with other currently available therapies.

Sign Up for Free e-newsletters